Literature DB >> 16760195

Acute progression of interstitial lung disease: a complication of etanercept particularly in the presence of rheumatoid lung and methotrexate treatment.

K Lindsay, R Melsom, B K Jacob, N Mestry.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16760195     DOI: 10.1093/rheumatology/kel090

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  8 in total

Review 1.  Lung disease in rheumatoid arthritis.

Authors:  Zulma X Yunt; Joshua J Solomon
Journal:  Rheum Dis Clin North Am       Date:  2015-02-03       Impact factor: 2.670

Review 2.  Treatment of rheumatoid arthritis-associated interstitial lung disease: a perspective review.

Authors:  Kundan Iqbal; Clive Kelly
Journal:  Ther Adv Musculoskelet Dis       Date:  2015-12       Impact factor: 5.346

3.  Changing trends in serious extra-articular manifestations of rheumatoid arthritis among United State veterans over 20 years.

Authors:  Christie M Bartels; Carolyn L Bell; Kazuhiko Shinki; Ann Rosenthal; Alan J Bridges
Journal:  Rheumatology (Oxford)       Date:  2010-05-12       Impact factor: 7.580

4.  Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register.

Authors:  W G Dixon; K L Hyrich; K D Watson; M Lunt; D P M Symmons
Journal:  Ann Rheum Dis       Date:  2010-05-05       Impact factor: 19.103

Review 5.  Chimeric fusion proteins used for therapy: indications, mechanisms, and safety.

Authors:  Brian A Baldo
Journal:  Drug Saf       Date:  2015-05       Impact factor: 5.228

Review 6.  Rheumatoid Arthritis and Associated Lung Diseases: A Comprehensive Review.

Authors:  Ahmad T Azam; Oladipo Odeyinka; Rasha Alhashimi; Sankeerth Thoota; Tejaswini Ashok; Vishnu Palyam; Ibrahim Sange
Journal:  Cureus       Date:  2022-02-18

Review 7.  Management of Rheumatoid Arthritis Patients with Interstitial Lung Disease: Safety of Biological Antirheumatic Drugs and Assessment of Pulmonary Fibrosis.

Authors:  Shunsuke Mori
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2015-09-08

Review 8.  Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows.

Authors:  Giulia Cassone; Andreina Manfredi; Caterina Vacchi; Fabrizio Luppi; Francesca Coppi; Carlo Salvarani; Marco Sebastiani
Journal:  J Clin Med       Date:  2020-04-10       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.